Ad
related to: lung, vomiting
Search results
Whooping cough cases on the rise nationwide
CBS News· 6 days agoRising whooping cough cases are raising health concerns nationwide, including in Pennsylvania. No parent wants their child to suffer from pertussis, also...
Bear meat for dinner? Follow these steps to prevent parasitic infection, CDC says
Fox News· 7 days agoEating undercooked meat from wild game animals can cause a rare illness known as trichinellosis,...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 7 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
More help coming for Finley residents caught in Lineage smoke plume. Box fan giveaway set
Tri-City Herald via Yahoo News· 6 days agoOther residents said they had migraines, bronchitis and frequent doctor visits as the smoke has...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 4 days agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants
Fortune· 1 day ago“This is not a surprise; this is always in the cards,” Edwin Michael, PhD, an epidemiologist at the University of South Florida College of Public Health, tells Fortune. “The mutations will keep ...
Alvesco: Side effects and what to do about them
Medical News Today· 2 days agoAlvesco (ciclesonide) is a brand-name inhaled corticosteroid that’s prescribed for asthma in adults and certain children. As with other drugs, Alvesco...
Veterinary hospital teamwork helps dog survive toxic ingestion
Roanoke Times· 5 days agoAttentive action and a trip to the Virginia-Maryland College of Veterinary Medicine’s Teaching...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 5 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 5 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO ...